LAVA Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $227 | $6,992 | $353 |
Gross Profit | -228 | 6,992 | 199 |
EBITDA | -9,241 | -1,808 | -5,259 |
EBIT | -9,469 | -1,952 | -5,442 |
Net Income | -8,296 | -553 | -6,498 |
Net Change In Cash | 227 | 6,992 | 353 |
Free Cash Flow | -8,384 | -1,125 | -10,111 |
Cash | 35,086 | 43,187 | 44,230 |
Basic Shares | 26,822 | 26,794 | 26,769 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $6,769 | $19,391 | $5,000 | $3,747 |
Gross Profit | 3,287 | 19,391 | 5,000 | -11,954 |
EBITDA | -40,417 | -30,877 | -43,795 | -14,652 |
EBIT | -41,695 | -31,381 | -44,353 | -14,865 |
Net Income | -41,974 | -31,907 | -45,347 | -15,927 |
Net Change In Cash | 6,769 | 19,391 | 5,000 | 3,747 |
Free Cash Flow | -39,702 | 3,456 | -33,343 | -13,424 |
Cash | 44,231 | 100,333 | 151,013 | 19,429 |
Basic Shares | 26,732 | 25,924 | 19,758 | 25,352 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.43 |
2024-06-30 | -$0.31 |
2024-03-31 | -$0.02 |
2023-12-31 | -$0.24 |
